Pricing Log in Create free account
Saturday 17 October 2026 Export RVTY’s income statement to Excel — free account

Revvity Inc.

RVTY Healthcare Diagnostics & Research

Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024. In the quarter to June 2026, revenue grew 1.31%, EPS grew 2.17%, free cash flow grew 59.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

152.64 2.07 −1.34%
Market cap
$17.3B
P/E
72.7×
Fwd P/E
37.5×
Dividend yield
0.23%
F-score
6/9
Altman Z
2.49
Beneish M
−2.45
Dividend safety
80/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Revvity Inc. (RVTY) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, Revvity Inc. (RVTY) trades at a price to free cash flow of 30.1×. Over the past ten years it has ranged from 0.0× (December 2023) to 2,840× (January 2024); the current reading is higher than 69% of that period. That is below the Diagnostics & Research industry median of 35.8× and above the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 22.4× (12.44%)
FY2024 25.5× (99.09%)
FY2023 2,808× 9,192.01%
FY2022 30.2× 70.76%
FY2021 17.7× (8.45%)
FY2020 19.3× (49.22%)
FY2019 38.1× 12.13%
FY2018 33.9× 4.72%
FY2017 32.4× 89.95%
FY2016 17.1× (26.69%)

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 22.0× 11.34%
Mar 2026 19.7× (11.74%)
Dec 2025 22.4× 8.81%
Sep 2025 20.5× (9.99%)
42 more quarters

Against its own ten years

Low 0.0× High 2,840×
Ten-year median 24.6×
Current reading's percentile 69

Price to free cash flow against peers

Company Price to free cash flow
TWST Twist Bioscience Corporation compare n/m
GH Guardant Health, Inc. compare n/m
ICLR ICON PLC compare 14.8×
DGX Quest Diagnostics Incorporated compare 19.3×
QGEN QIAGEN N.V. compare 21.6×
MEDP Medpace Holdings, Inc. compare 24.7×
LH Labcorp Holdings Inc. compare 25.2×
RVTY Revvity Inc. 30.1×
CRL Charles River Laboratories International, Inc. compare 38.8×
Diagnostics & Research industry median 35.8×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on RVTY